Filing Flows › Comparisons › ABSI vs ISPC
Absci vs iSpecimen: ABSI and ISPC compared
Absci is the larger company: $318K of revenue in its latest quarter (Q2 2026) against $152K for iSpecimen (Q2 2026). Absci is growing faster (-46% against -79% a year earlier).
Where the money goes: ABSI and ISPC
Absci (ABSI) · Q2 2026
Absci, Q2 2026: revenue $318K (-46% year over year), net loss $33.2M, operating cash flow −$27.6M. The chart follows the revenue to costs, profit and cash.
iSpecimen (ISPC) · Q2 2026
iSpecimen, Q2 2026: revenue $152K (-79% year over year), operating margin -897.1%, net loss $1.4M, operating cash flow −$690K. The chart follows the revenue to costs, profit and cash.
| Absci (ABSI) | iSpecimen (ISPC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $318K | $152K |
| Revenue growth, Y/Y | -46% | -79% |
| Operating margin | n/m | -897.1% |
| Net earnings | −$33.2M | −$1.4M |
| Net margin | — | -896.9% |
| Operating cash flow | −$27.6M | −$690K |
Where the revenue comes from
iSpecimen
- Product: $125K (83%)
- Shipping and Handling: $27K (17%)
Questions
Which is bigger, Absci or iSpecimen?
Absci is the larger company: $318K of revenue in its latest quarter (Q2 2026) against $152K for iSpecimen (Q2 2026).
Is Absci or iSpecimen growing faster?
Absci is growing faster (-46% against -79% a year earlier).
More: Absci earnings · how Absci makes money · iSpecimen earnings · how iSpecimen makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.